scholarly journals Changes in nomenclature of upper Precambrian to lower Paleozoic(?) formations in the Natick quadrangle, eastern Massachusetts, and their tentative correlations with rocks in Rhode Island and Connecticut

1974 ◽  
Keyword(s):  
Rhode Island ◽  
Lower Paleozoic ◽  
Eastern Massachusetts

Flood of March 1968 in eastern Massachusetts and Rhode Island

1970 ◽  
Author(s):  
G.K. Wood ◽  
L.A. Swallow ◽  
C.G. Johnson ◽  
G.H. Searles
Keyword(s):  
Rhode Island ◽  
Eastern Massachusetts

scholarly journals Acute thrombocytopenic purpura in relation to the use of drugs

Blood ◽  
1993 ◽  
Vol 82 (9) ◽  
pp. 2714-2718 ◽  
Author(s):  
DW Kaufman ◽  
JP Kelly ◽  
CB Johannes ◽  
A Sandler ◽  
D Harmon ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Rhode Island ◽  
Case Control Study ◽  
Case Control ◽  
Incidence Rates ◽  
Acute Onset ◽  
Multiple Logistic Regression ◽  
Thrombocytopenic Purpura ◽  
Eastern Massachusetts ◽  
Control Study

Abstract The relation of acute thrombocytopenic purpura (TP) to the use of drugs was investigated in a case-control study conducted in eastern Massachusetts, Rhode Island, and the Philadelphia region; 62 cases over the age of 16 years with acute onset and with a rapid recovery were compared with 2,625 hospital controls. After control for confounding by multiple logistic regression, use of the following drugs in the week before the onset of symptoms was significantly associated: trimethoprim/sulfamethoxazole (relative risk [RR] estimate, 124), quinidine/quinine (101), dipyridamole (14), sulfonylureas (4.8), and salicylates (2.6). The overall annual incidence of acute TP was estimated to be 18 cases per million population. The excess risks for the associated drugs were estimated to be 38 cases per million users of trimethoprim/sulfamethoxazole per week, 26 per million for quinidine/quinine, 3.9 per million for dipyridamole, 1.2 per million for sulfonylureas, and 0.4 per million for salicylates. Associations with sulfonamides, quinidine/quinine, sulfonylureas, and salicylates have been previously reported, but the present study has provided the first quantitative measures of the risk. The association with dipyridamole was unexpected. In general, despite large RRs, the incidence rates attributable to the drugs at issue (excess risks) were low, suggesting that TP is not an important consideration in the use of the various drugs.

scholarly journals Acute thrombocytopenic purpura in relation to the use of drugs

Blood ◽  
1993 ◽  
Vol 82 (9) ◽  
pp. 2714-2718
Author(s):  
DW Kaufman ◽  
JP Kelly ◽  
CB Johannes ◽  
A Sandler ◽  
D Harmon ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Rhode Island ◽  
Case Control Study ◽  
Case Control ◽  
Incidence Rates ◽  
Acute Onset ◽  
Multiple Logistic Regression ◽  
Thrombocytopenic Purpura ◽  
Eastern Massachusetts ◽  
Control Study

The relation of acute thrombocytopenic purpura (TP) to the use of drugs was investigated in a case-control study conducted in eastern Massachusetts, Rhode Island, and the Philadelphia region; 62 cases over the age of 16 years with acute onset and with a rapid recovery were compared with 2,625 hospital controls. After control for confounding by multiple logistic regression, use of the following drugs in the week before the onset of symptoms was significantly associated: trimethoprim/sulfamethoxazole (relative risk [RR] estimate, 124), quinidine/quinine (101), dipyridamole (14), sulfonylureas (4.8), and salicylates (2.6). The overall annual incidence of acute TP was estimated to be 18 cases per million population. The excess risks for the associated drugs were estimated to be 38 cases per million users of trimethoprim/sulfamethoxazole per week, 26 per million for quinidine/quinine, 3.9 per million for dipyridamole, 1.2 per million for sulfonylureas, and 0.4 per million for salicylates. Associations with sulfonamides, quinidine/quinine, sulfonylureas, and salicylates have been previously reported, but the present study has provided the first quantitative measures of the risk. The association with dipyridamole was unexpected. In general, despite large RRs, the incidence rates attributable to the drugs at issue (excess risks) were low, suggesting that TP is not an important consideration in the use of the various drugs.

The New England earthquake of January 7, 1925

1924 ◽  
Vol 14 (4) ◽  
pp. 233-239
Author(s):  
William W. Porter
Keyword(s):  
New England ◽  
Rhode Island ◽  
New Hampshire ◽  
Maximum Intensity ◽  
Epicentral Area ◽  
Disturbed Area ◽  
Eastern Massachusetts ◽  
Earthquake Area

Summary An earthquake occurred on the morning of January 7, 1925. It was felt in eastern Massachusetts, and adjacent parts of Rhode Island, New Hampshire, and Maine. Distance from Harvard seismograph forty-five kilometers. Epicentral area thought to be near Cape Ann. Not felt at sea. Closely related to an earthquake area in northeast Massachusetts. Radius of periphery of disturbed area from epicentral area,—maximum seventy-five miles, minimum fifty miles. Maximum intensity barely V, Rossi-Forel Scale.

Use of the AMA Guides in State Workers' Compensation Systems: 2009 Update

2009 ◽  
Vol 14 (2) ◽  
pp. 13-16
Author(s):  
Christopher R. Brigham ◽  
Jenny Walker
Keyword(s):  
New York ◽  
North Carolina ◽  
South Carolina ◽  
South Dakota ◽  
Rhode Island ◽  
Workers Compensation ◽  
Fourth Edition ◽  
Sixth Edition ◽  
Specific Guideline ◽  
Compensation Systems

Abstract The AMAGuides to the Evaluation of Permanent Impairment (AMA Guides) is the most widely used basis for determining impairment and is used in state workers’ compensation systems, federal systems, automobile casualty, and personal injury, as well as by the majority of state workers’ compensation jurisdictions. Two tables summarize the edition of the AMA Guides used and provide information by state. The fifth edition (2000) is the most commonly used edition: California, Delaware, Georgia, Hawaii, Kentucky, New Hampshire, Idaho, Indiana, Iowa, Kentucky, Massachusetts, Nevada, North Dakota, Ohio, Vermont, and Washington. Eleven states use the sixth edition (2007): Alaska, Arizona, Louisiana, Mississippi, Montana, New Mexico, Oklahoma, Pennsylvania, Rhode Island, Tennessee, and Wyoming. Eight states still commonly make use of the fourth edition (1993): Alabama, Arkansas, Kansas, Maine, Maryland, South Dakota, Texas, and West Virginia. Two states use the Third Edition, Revised (1990): Colorado and Oregon. Connecticut does not stipulate which edition of the AMA Guides to use. Six states use their own state specific guidelines (Florida, Illinois, Minnesota, New York, North Carolina, and Wisconsin), and six states do not specify a specific guideline (Michigan, Missouri, Nebraska, New Jersey, South Carolina, and Virginia). Statutes may or may not specify which edition of the AMA Guides to use. Some states use their own guidelines for specific problems and use the Guides for other issues.

Sign in / Sign up

Export Citation Format

Share Document